Integrative Analysis of Large-cell Lung Cancer

NCT02917369 · tracked via the Priya Life Science China tracker

Sponsor

Shanghai 10th People's Hospital

Phase

Observational

Started

2016-01

Last updated

2016-09-28

Condition(s) studied

Lung Cancer

Investigational drug(s) / intervention(s)

Normal lung tissue

Normal lung tissue: The investigators will extract total protein, DNA and RNA from LCLC patients.

Study summary

Integrative analysis of LCLC

Eligibility

Sex

ALL

Min age

18 Years

Max age

75 Years

Healthy volunteers

Inclusion Criteria: * Age ≤ 75 years with histologically proven LCLC * No severe major organ dysfunction * World Health Organization (WHO) performance status of 0 or 1 * No prior cancer chemotherapy Exclusion Criteria: * Age ≥ 76 * Severe major organ dysfunction * WHO performance status of \>1 * Prior cancer chemotherapy

Primary outcome measure(s)

5 years overall survival — 5 years

Trial sites (3)

Facility	City	Region	Status
Ganzhou City People's Hospital	Ganzhou	Jiangxi	Recruiting
Shanghai Tenth People's Hospital	Shanghai	Shanghai Municipality	Recruiting
Shanghai Pulmonary Hospital	Shanghai	Shanghai Municipality	Recruiting

More Shanghai 10th People's Hospital trials in China

Study of the Closed-loop Treatment Concept of Atrial Fibrillation in the Atrial Fibrillation Population Recruiting

D615L vs Zeiss 839MP: Visual Quality Active, not recruiting

A Multicenter Clinical Study on Protein Absorption Efficiency in Patients With Pancreatic Exocrine Insufficiency in the ICU Starting soon

Efficacy and Safety of Coenzyme I for Injection on Vascular Aging. Starting soon

Multidisciplinary Diagnosis and Treatment of Polycystic Ovary Syndrome Recruiting

Other trials for the same condition

Research on Early Screening and Diagnosis of Pulmonary Nodules Based on Novel Non-invasive Technologies. Recruiting

Study on the Diagnosis of Ground-glass Lung Cancer by Microwave Ablation Combined With Puncture Biopsy Recruiting

Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer Recruiting

Application of DCE-MRI Based on 4D FreeBreathing in Predicting the Efficacy of Immune and Targeted Therapy in Lung Cancer Recruiting

Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02917369 on ClinicalTrials.gov ↗ ← All trials in China